ContractDelaware • May 5th, 2020
Jurisdiction FiledMay 5th, 2020EX-10.85 3 opiant_consortxfinalreimba.htm EXHIBIT 10.85 Exhibit 10.85 CONFIDENTIALTREATMENT REQUESTED CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION EXECUTION COPY AGREEMENT FOR REIMBURSEMENT OF CAPITAL EXPENDITURE AND SERVICE FEES BETWEEN AESICA QUEENBOROUGH LIMITED And OPIANT PHARMACEUTICALS INC relating to the development, manufacture and supply of a device capable of administering Nalmefene hydrochloride Exhibit 10.85 Contents CLAUSE
AGREEMENT FOR REIMBURSEMENT OF CAPITAL EXPENDITURE AND SERVICE FEES BETWEEN AESICA QUEENBOROUGH LIMITED And OPIANT PHARMACEUTICALS INC relating to the development, manufacture and supply of a device capable of administering Nalmefene hydrochlorideOpiant Pharmaceuticals, Inc. • September 10th, 2018 • Metal mining • Delaware
Company FiledSeptember 10th, 2018 Industry Jurisdiction